Updated:
Friedman Bioventures
Friedman Bioventures is a San Diego-based private equity firm investing in early-stage healthcare and life sciences, including therapeutics and medical...
Friedman Bioventures
Friedman Bioventures is a private equity firm based in San Diego, US. It focuses on venture capital investments.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Sector focus
Frequently asked questions
What investment stages does Friedman Bioventures typically target?
The firm focuses on early-stage investments, specifically startup and seed-stage companies in the healthcare and life sciences sectors (per public record). It does not typically participate in later-stage or growth-equity rounds.
Which sectors does Friedman Bioventures focus on?
Friedman Bioventures invests in therapeutics, medical devices, diagnostics, and digital health (public record). The firm's portfolio companies generally have identified clinical needs and regulatory pathways.
Does Friedman Bioventures participate in fund commitments or only direct deals?
The firm primarily engages in direct equity investments and co-investments alongside other healthcare-focused venture funds (public record). It does not publicly disclose commitments to third-party fund vehicles.
Who runs investment decisions at Friedman Bioventures?
The firm does not publicly identify its investment team or leadership on its website or in public records. No named principals or professionals are available from disclosed sources.
Where does Friedman Bioventures focus geographically?
The firm is based in San Diego and concentrates on North American opportunities, particularly in the California, Boston, and San Francisco biotech hubs (public record). It may consider select international deals but does not disclose a broader mandate.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: